Athira Pharma, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Perceptive Advisors LLC and its affiliates have amended their Schedule 13D filing for LeonaBio, Inc., reporting beneficial ownership of 19.99% and announcing the appointment of Fred Callori to the company's board.
Perceptive Advisors LLC and its affiliates have updated their beneficial ownership in LeonaBio, Inc. to 19.99% of common stock, subject to a beneficial ownership limitation.
Perceptive Advisors and its affiliates have increased their beneficial ownership in Athira Pharma, Inc. to 20.1% following recent stock and warrant acquisitions.
SCHEDULE 13D/A: Athira Pharma Secures Major Investment, Licenses New Drug
Athira Pharma, Inc. announced a significant private placement led by Perceptive funds and an exclusive licensing agreement for lasofoxifene, involving substantial warrant issuances.